Blood test to monitor for remaining cancer after ovarian cancer treatment
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study uses a simple blood test to look for tiny amounts of cancer DNA after you've finished your first treatment. It aims to see if this test can predict whether the cancer might come back, which could help guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 19 or older.
- You have been diagnosed with a common type of ovarian cancer (high-grade serous, endometrioid, clear cell, or mixed).
- Your cancer was at stage III or IV at diagnosis.
- You have finished surgery and platinum-based chemotherapy, and your scans show no cancer left (complete response). You may be on maintenance therapy such as bevacizumab or a PARP inhibitor.
- You have no other active cancer and no condition that makes blood tests unsafe.
- You are willing to give blood samples for this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether a simple blood test can predict the risk of ovarian cancer coming back after treatment. It might help doctors decide who needs more aggressive therapy.
This study looks at blood samples from people with ovarian cancer to measure a marker called ctDNA (bits of tumor DNA in the blood). The goal is to see if changes in this marker before and after surgery can help predict or monitor the cancer.
This study is testing a new blood test that looks for DNA changes to help detect ovarian cancer earlier. You would give a blood sample before your planned surgery or biopsy, and researchers will compare the test results with your pathology report to see how accurate it is.
This study uses a simple blood test to look for tiny bits of cancer DNA after your treatment. It aims to see if this test can help predict whether the cancer might come back.
This study uses a custom lab test on blood (and tumor tissue) to track ovarian cancer returning and to see how well treatment is working. It may help your care team monitor changes over time, especially after certain surgeries.
This study looks for cancer DNA in your blood to understand advanced ovarian cancer better. It helps doctors see how the disease changes over time and may improve future treatments.
Hear when a new Ovarian Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.